logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Matthias Christgen

Hannover Medical School
H指数:38
被引数:5,349

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reduced folate receptor alpha (FOLR1) protein expression in fallopian tubes from premenopausal women: implications for the FOLR1 CDx assay for mirvetuximab-soravtansine therapy

减低叶酸受体α（FOLR1）蛋白在绝经前女性输卵管中的表达：对mirvetuximab-soravtansine疗法FOLR1 CDx检测的影响

The Journal of Pathology: Clinical Research
IF3.7
2026-04-230
OAAI
Annika Nasdala; Leonie D Kandt; Martin Radner; Nora Schaumann; Malte Gronewold; Pia Hillmann; Henriette Christgen; Jens Hachenberg; Elna Kuehnle; Christian Hartmann; Matthias Christgen
Refining Risk Assessment for Adjuvant CDK4/6 Inhibitors beyond Trial Inclusion Criteria: Integrating Recurrence Score and Endocrine Responsiveness according to ADAPT

Braun, M.; Gluz, O.; Kuemmel, S.; Nitz, U.; Luedtke-Heckenkamp, K.; Darsow, M.; Forstbauer, H.; Polata, S.; Grischke, E.M.; Uleer, C.; et al. 优化辅助CDK4/6抑制剂的危险度评估：超越试验纳入标准，根据ADAPT整合复发评分和内分泌应答。Breast Care 2026. online ahead of print. [Google Scholar] [CrossRef]

Breast Care
IF2.1
2026-02-010
PRE
Braun, Michael; Gluz, Oleg; Kuemmel, Sherko; Nitz, Ulrike; Luedtke-Heckenkamp, Kerstin; Darsow, Maren; Forstbauer, Helmut; Polata, Silke; Grischke, Eva-Maria; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Zu Eulenburg, Christine; Kates, Ronald; Burmeister, Sandy; Graeser, Monika; Wuerstlein, Rachel; Baehner, Rick; Christgen, Matthias; Kreipe, Hans Heinrich; Harbeck, Nadia
Integrative analysis of RNA expression signatures and recurrent genomic alterations before treatment: link to menopausal status, short-term endocrine therapy response and disease-free survival in luminal breast cancer

RNA表达特征与复发基因组改变的整合分析：治疗前与绝经状态、短期内分泌治疗反应及无病生存期的关联性研究（在腔面乳腺癌中）

ESMO Open
IF8.3
2025-11-210
OAAI
G. Zhang; H. Ni; L. Mishieva; S. Bartels; M. Christgen; H. Christgen; L.D. Kandt; M. Raap; R.E. Kates; O. Gluz; M. Graeser; S. Kümmel; U. Nitz; C. Plass; U. Mansmann; C. zu Eulenburg; C. Gerhäuser; H.H. Kreipe; N. Harbeck
Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP®)

德国病理学质量保证倡议（QuIP®）首次叶酸受体α检测试验的结果

Cancers 2025, Vol. 17, Page 3703
IF4.4
2025-11-190
OAAI
Alexander Scheiter; Sven Mattern; Verena Gassenmaier; Hans-Ulrich Schildhaus; Matthias Christgen; Hans Kreipe; Hermann Herbst; Bettina Lambert; Guido Sauter; Maximilian Lennartz; Korinna Jöhrens; Florian Sperling; Afschin Soleiman; Ramona Erber; Stephan Singer; Annette Staebler; Kirsten Utpatel
The Janus Face of SPAG6: Inducing EMT in Luminal Breast Cancer Cells Amidst Widespread Expression Loss in Breast Tumours

SPAG6的两面性：在乳腺肿瘤中SPAG6表达广泛缺失的背景下，诱导乳腺导管癌细胞发生EMT

Journal of Cellular and Molecular Medicine
IF4.2
2025-10-090
OAAI
Antonio Sechi; Jolein Mijnes; Sophia Villwock; Michael Rose; Florian Steib; Sarah Bringezu; Jonas Berger; Carmen Schalla; Sonja von Serenyi; Jana Dietrich; Nadina Ortiz-Brüchle; Lara Heij; Jan Bednarsch; Oleg Gluz; Ulrike Nitz; Nadia Harbeck; Monika Graeser; Christine zu Eulenburg; Mohammad Parsa Mohammadian; Katarzyna Jóźwiak; Hans-Heinrich Kreipe; Matthias Christgen; Martin Radner; Danny Jonigk; Edgar Dahl
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and nonresponders

一个预测性内分泌抵抗指数能够准确地对腔面型乳腺癌治疗反应者和非反应者进行分层。

JOURNAL OF CLINICAL INVESTIGATION
IF13.6
2025-10-012
OA
Zhang, Guokun; Jurinovic, Vindi; Bartels, Stephan; Christgen, Matthias; Christgen, Henriette; Kandt, Leonie Donata; Mishieva, Lidiya; Ni, Hua; Raap, Mieke; Klein, Janin; Katzke, Anna-Lena; Hofmann, Winfried; Steinemann, Doris; Kates, Ronald E.; Gluz, Oleg; Graeser, Monika; Kummel, Sherko; Nitz, Ulrike; Plass, Christoph; Lehmann, Ulrich; Eulenburg, Christine zu; Mansmann, Ulrich; Gerhauser, Clarissa; Harbeck, Nadia; Kreipe, Hans H.
Clinicopathological Characteristics of a Distinct Tumor Phenotype: Invasive Lobular Carcinoma With Tubular Elements in the West German Study Group ADAPTcycle Trial
LABORATORY INVESTIGATION
IF4.2
2025-06-010
OA
Radner, Martin; Burmeister, Sandy; Jozwiak, Katarzyna; Schaumann, Nora; Gronewold, Malte; Raap, Mieke; Bartels, Stephan; Christgen, Henriette; Kandt, Leonie D.; Hillmann, Pia; Lehmann, Ulrich; Gluz, Oleg; Graeser, Monika; Kuemmel, Sherko; zu Eulenburg, Christine; Harbeck, Nadia; Kreipe, Hans; Christgen, Matthias
Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial

免疫调节基因网络预测在WSG-ADAPT-TN试验中，三阴性乳腺癌对降级、无蒽环类的新辅助化疗的治疗反应和生存情况。

MOLECULAR CANCER
IF33.9
2025-03-260
OA
Korbie, Darren; Stirzaker, Clare; Gluz, Oleg; zu Eulenburg, Christine; Nitz, Ulrike; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Wuerstlein, Rachel; Pelz, Enrico; Kreipe, Hans Heinrich; Clark, Susan J.; Trau, Matt; Graeser, Monika; Harbeck, Nadia
Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer A Secondary Analysis of a Randomized Clinical Trial

三阴性乳腺癌患者中的基因改变、治疗反应和生存情况：一项随机临床试验的二次分析

JAMA NETWORK OPEN
IF9.7
2025-02-260
OA
Richters, Lisa; Gluz, Oleg; Weber-Lassalle, Nana; Christgen, Matthias; Haverkamp, Heinz; Kuemmel, Sherko; Kayali, Mohamad; Kates, Ronald E.; Grischke, Eva-Maria; Altmueller, Janine; Forstbauer, Helmut; Thiele, Holger; Braun, Michael; Warm, Mathias; Ossowski, Anna; Wuerstlein, Rachel; Ernst, Corinna; Graeser, Monika; Linn, Sabine C.; Nitz, Ulrike; Hauke, Jan; Kreipe, Hans Heinrich; Schmutzler, Rita K.; Hahnen, Eric; Harbeck, Nadia
HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN
BREAST CANCER RESEARCH
IF5.6
2025-02-140
OAAI
Schmidt, Gilda; Gluz, Oleg; Christgen, Matthias; Reinisch, Mattea; Kuemmel, Sherko; Nitz, Ulrike; Braun, Michael; Aktas, Bahriye; Luedtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Schumacher, Claudia; Mahlberg, Rolf; Malter, Wolfram; Reimer, Toralf; Nuding, Benno; Stefek, Andrea; Wuerstlein, Rachel; Graeser, Monika; Jozwiak, Katarzyna; Burmeister, Sandy; zu Eulenburg, Christine; Lauseker, Michael; Kolberg-Liedtke, Cornelia; Prat, Aleix; Schmid, Peter; Baehner, Rick; Kreipe, Hans Heinrich; Solomayer, Erich-Franz; Harbeck, Nadia; West German Study Grp Investigators
Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers
BREAST CANCER RESEARCH
IF5.6
2025-01-240
OAAI
Haeberle, Lothar; Erber, Ramona; Gass, Paul; Hein, Alexander; Niklos, Melitta; Volz, Bernhard; Hack, Carolin C.; Schulz-Wendtland, Ruediger; Huebner, Hanna; Goossens, Chloe; Christgen, Matthias; Doerk, Thilo; Park-Simon, Tjoung-Won; Schneeweiss, Andreas; Untch, Michael; Nekljudova, Valentina; Loibl, Sibylle; Hartmann, Arndt; Beckmann, Matthias W.; Fasching, Peter A.
Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium
MODERN PATHOLOGY
IF5.5
2024-07-015
OAAI
De Schepper, Maxim; Koorman, Thijs; Richard, Francois; Christgen, Matthias; Vincent-Salomon, Anne; Schnitt, Stuart J.; van Diest, Paul J.; Zels, Gitte; Mertens, Freya; Maetens, Marion; Vanden Bempt, Isabelle; Harbeck, Nadia; Nitz, Ulrike; Graser, Monika; Kuemmel, Sherko; Gluz, Oleg; Weynand, Birgit; Floris, Giuseppe; Derksen, Patrick W. B.; Desmedt, Christine
Individual patient data meta-analysis of clinical and translational biomarkers for prediction of pathological complete response (pCR) after de-escalated therapy in HER2+breast cancer in four trials of the West German Study Group
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Graeser, Monika; Gluz, Oleg; zu Eulenburg, Christine; Kuemmel, Sherko; von Schumann, Raquel; Christgen, Matthias; Wuerstlein, Rachel; Pelz, Enrico; Kreipe, Hans-Heinrich; Schmid, Peter; Thill, Marc; Braun, Michael; Potenberg, Jochem; Schumacher, Claudia; Tio, Joke; Hartkopf, Andreas; Just, Marianne; Schem, Christian; Ludtke-Heckenkamp, Kerstin; Grischke, Eva-Maria; Hilpert, Felix; Kentsch, Angela; Kates, Ronald; Nitz, Ulrike; Harbeck, Nadia
Multi-modal artificial intelligence models from baseline histopathology predict prognosis in HR+HER2-early breast cancer
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Kates-Harbeck, Daniel; Kreipe, Hans-Heinrich; Gluz, Oleg; Christgen, Matthias; Kuemmel, Sherko; Graeser, Monika; Nitz, Ulrike; Mahner, Sven; Mayr, Doris; Wuerstlein, Rachel; Mitani, Akinori; Zhang, Jingbin; Pinckaers, Hans; Ren, Yi; Wood, Peter; Griffin, Jacqueline; Feng, Felix; Esteva, Andre; Keim-Malpass, Jess; Kates, Ronald; Harbeck, Nadia
Impact of age and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Results from the multicenter ADAPTcycle trial (n=4,334)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Gluz, Oleg; Christgen, Matthias; Nitz, Ulrike; Kuemmel, Sherko; Braun, Michael; Thill, Marc; Wuerstlein, Rachel; Wimberger, Pauline; Hartkopf, Andreas; Schem, Christian; Zaiss, Matthias; Bjelic-Radisic, Vesna; Just, Marianne; Veselinovic, Kristina; Vincent, Myriam; Graeser, Monika; Krauss, Katja; Hoffmann, Oliver; Ludtke-Heckenkamp, Kerstin; Kates, Ronald; zu Eulenburg, Christine; Jozwiak, Katarzyna; Burmeister, Sandy; Baehner, Rick; Schmid, Peter; Kreipe, Hans-Heinrich; Harbeck, Nadia
Impact of age and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Results from the multicenter WSG-ADAPTcycle trial (n=5,290)
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Gluz, Oleg; Christgen, Matthias; Nitz, Ulrike; Kuemmel, Sherko; Braun, Michael; Thill, Marc; Wuerstlein, Rachel; Wimberger, Pauline; Hartkopf, Andreas; Schem, Christian; Zaiss, Matthias; Bjelic-Radisic, Vesna; Just, Marianne; Veselinovic, Kristina; Vincent, Myriam; Graeser, Monika; Krauss, Katja; Hoffmann, Oliver; Ludtke-Heckenkamp, Kerstin; Kates, Ronald; Eulenburg, Christine Zu; Schmid, Peter; Baehner, Rick; Kreipe, Hans-Heinrich; Harbeck, Nadia
HER2DX genomic assay in triple-negative breast cancer (TNBC) patients treated with 12-weeks of neoadjuvant chemotherapy: a correlative analysis from WSGADAPT-TN phase II trial
CANCER RESEARCH
IF16.6
2024-05-020
PRE
Gluz, Oleg; Braso-Maristany, Fara; Nitz, Ulrike; Pare, Laia; Christgen, Matthias; Villacampa, Guillermo; Conte, Benedetta; Kuemmel, Sherko; Kates, Ronald; Kolberg-Liedtke, Cornelia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Vivancos, Ana; Wuerstlein, Rachel; Parker, Joel S.; Graeser, Monika; Perou, Charles M.; zu Eulenburg, Christine; Villagrasa, Patricia; Kreipe, Hans-Heinrich; Prat, Aleix; Harbeck, Nadia

研究方向

暂未获取到该数据
N
Nadia Harbeck
H 指数:131论文数:2,063被引数:8.5万
O
Oleg Gluz
H 指数:38论文数:417被引数:6,724
H
Hans Kreipe
H 指数:78论文数:712被引数:2.4万
U
Ulrike Nitz
H 指数:39论文数:401被引数:1.3万
R
Ronald Kates
H 指数:42论文数:357被引数:6,721
R
Rachel Wuerstlein
H 指数:38论文数:475被引数:5,749
M
Michael Braun
H 指数:46论文数:388被引数:8,311
U
Ulrich Lehmann
H 指数:52论文数:316被引数:1.0万
S
Stephan Bartels
H 指数:20论文数:85被引数:1,030
S
Sherko Küemmel
H 指数:33论文数:234被引数:5,350